Cisapride Suspension and Utibron Neohaler
Determining the interaction of Cisapride Suspension and Utibron Neohaler and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Cisapride in no longer on the market in the US. Do not take cisapride with any other medication.
Professional:GENERALLY AVOID: Concomitant administration of anticholinergic agents would be expected to compromise the beneficial effects of cisapride. Cisapride enhances the release of acetylcholine to produce increased gastrointestinal motility. Anticholinergic agents by blocking this action could delay gastric emptying and worsen esophageal reflux.
MANAGEMENT: This combination should be avoided.
- "Product Information. Propulsid (cisapride)." Janssen Pharmaceutica, Titusville, NJ.
Generic Name: cisapride
Brand name: Propulsid
Synonyms: Cisapride Tablets
Generic Name: glycopyrrolate / indacaterol
Brand name: Utibron Neohaler
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cisapride Suspension-Uticap
- Cisapride Suspension-Utira-C
- Cisapride Suspension-Utira-C Tablets
- Cisapride Suspension-Utrona-C
- Cisapride Suspension-Uvadex
- Cisapride Suspension-Uvadex injection
- Utibron Neohaler-Cisapride Tablets
- Utibron Neohaler-Cisatracurium
- Utibron Neohaler-Cisatracurium Besylate
- Utibron Neohaler-Cisatracurium Besylate Injection
- Utibron Neohaler-Cisatracurium besylate Intravenous
- Utibron Neohaler-Cisplatin